San Francisco, Fall 2011

Health 2.0 San Francisco Fall 2011 Code-a-Thon

$13,000 to be offered in prizes for best projects

Date: Saturday, September 24th and Sunday, September 25th
Location: pariSoma Innovation Loft, 169 11th Street (at Natoma), San Francisco (map)

san francisco code-a-thon

Register for Washington, D.C. Code-a-thon in Washington, DC  on Eventbrite

Please join us for a special 2-day code-a-thon running the weekend before our flagship fall conference. We expect to put on our largest code-a-thon ever with innovators from throughout the Bay Area joining us for an intense and enjoyable weekend of hacking, developing and creating. We will be featuring a number of excellent tech talks from our invited speakers who will talk about cutting edge issues in technology. The event culminates in an all-star judging session with the best creations taking home a cash prize!

HOW DO I REGISTER?
Registration is FREE, but you must sign up so we can save a sandwich and a seat for you! You can register HERE.

WILL THERE BE FOOD?
We will provide you with fuel all day. Just bring yourself, your laptops and your brainpower.

HOW DO I GET THERE?
The event will be at the pariSoma innovation loft, located  169 11th Street (at Natoma st.) in San Francisco, California.

  • Parking: On street.  Parking meters are free on Sunday.
  • Public transit: many Muni busses run by and we are blocks from Van Ness Station (muni/metro) and Civic Center Station (muni/metro and BART).

SPONSORS:

  • Novartis (Offering a $3,000 Challenge – See below)

CONFIRMED SPEAKERS:

  • Joris Vandam, Novartis
  • Will Barkis, National Science Foundation (US Ignite Project)
  • Lew Altman, HIE
  • Mat Trudel, Massive Health (Mobile API Project)
  • Jan Gurley
  • Jun Yamadera, Eyes.Japan (Health20API)
  • Chris C. Haffer

AGENDA:

  • Saturday
    • 11:00-11:15 – Introduction, Breakfast and Opening Talks from Health 2.0 team
    • 11:15-11:30  – Novartis Challenge (Joris VanDam)
    • 11:30-11:45 – i2 Challenge (Matthew/Indu/Deb)
    • 11:45 – Team Proposals
    • 12:30 – Lunch
    • 12:30  – 8:00 PM – Build!
    • 12:30-12:45 - Tech Talk, Joris VanDam, Novartis
    • 1:00-1:15 – Matthew 101 Presentation
    • 1:15-1:30 – Marco 101 Presentation
    • 1:30-1:45 – Tech Talk, Will Barkis, NSF
    • 1:45-2:00 – Tech Talk, Lew Altman, HIE
    • 2:30-2:45 – Tech Talk, Mat Trudel, Massive
    • 2:45-3:00 - Jan Gurley
    • 3:30-3:45 – Jun Yamadera, eyes.Japan
    • 3:45-4:00 – Tech Talk, Chris C. Haffer
    • 6:30 – Dinner
    • 8:00 – Head out for drinks
  • Sunday
    • 9 am – Coding begins again
    • 3 pm – Final Presentations
    • 5 pm – Winners announced and reception

Register for Washington, D.C. Code-a-thon in Washington, DC  on Eventbrite

Description of the Novartis Challenge – Offering A Separate $3,000 Prize
Doctors, patients, and health care organizations are all starting to use a new generation of online and mobile technologies (“Apps”) which are fundamentally changing the way health care works. What we would like to learn, is what Apps could be developed for the patients and physicians that use our products – and whether we could stimulate the development of such Apps by providing easy access to information about our products. To that end, we will take a standard and publicly available product label for one of our drugs and make the data from that product label available through an online interface. Our challenge will be to develop Apps that use this product data to support the patients and physicians that use our drug, and ultimately to thereby improve the outcome of their treatment. You could think of, e.g., information about side effects, about dosage, about drug interactions, when and how to take the drugs, … – we will leave that up to the creativity of the participating teams!

There already exists documented evidence in particular disease areas that the use of such Apps improves treatment outcomes of patients. We have a vested interest in improving treatment outcomes of patients using our products – as that reinforces the market positioning of our drugs. Yet short of developing such Apps ourselves, which we don’t think is our core business, we would like to test whether we can stimulate the development of such Apps by providing better access to the data that we hold. In initial conversations with leading Academia, this strategy has been well received and highly praised.

Over and above the direct benefit to patient health outcomes, the use of such Apps can also generate valuable data to fuel our research in personalized medicine. Initial research has shown that if such Apps were to have a button that said “donate my (anonymous) health data to research”, that 80%-90% of patients would press that button without hesitation. This has tremendous potential for accelerating if not transforming various stages of research and development into personalized treatment solutions.

In short, we have many and compelling reasons to stimulate the use of Apps by the patients and physicians that use our products. And we believe that the sponsorship of this Development Challenge will provide valuable insights and feedback from the market how we can play a role in supporting that.